Leukaemia: populationbased study of and outcome

HIGHLIGHTS

• who: Acute promyelocytic leukaemia and colleagues from the according to , codingThe Laboratory Information System within CDARS was used to retrieve the presentation blood count. Specific information on APL, including the morphology, karyotype, and reverse transcription polymerase chain reaction for PML-RARA, was collected from individual patient records. The pathology reports were scrutinized for confirmation of the diagnosis of APL according to standard morphologic/karyotypic/molecular criteria [1]. The study was approved by the Institutional Review Board of the University of Hong Kong/Hong Kong West Cluster (UW, ), and formed part of the Acute Promyelocytic Leukaemia Asian Consortium . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.